Related Articles Biopharma Funds Deliver Market-Beating Returns as Valuations Snap Back Stephen Taub J.P. Morgan’s Michael Cembalest Finds ‘Warning Signs’ in Hedge Funds Michelle Celarier How ETFs Can Ease the Complexity of Duration Management Sponsored by Northern Trust Asset Management